Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
The objective of this article is to discuss the paradigm shift in how companies plan for and deliver on the “long tail” of a drug’s impact even after Loss of Exclusivity (LoE) – a process known as lifecycle management (LCM).
Drawing on insights from a roundtable of industry leaders convened by Klick at the recent MAPS conference, let’s look at how viewing the KOL holistically can lead to new avenues of engagement and more multifaceted relationships.
In this podcast, we speak with Jill Donahue, author of the recently published (free!) book, “A Dose of Inspiration: 100 Purpose Stories from Pharma Leaders” about the individual and organizational benefits of discovering your purpose as an employee in the Life Sciences industry.
Influence is an inside-out game, requiring us to look inward before we lead outward.
if you start your day in work mode (4th & 5th gears), and you drive all day like that, you are going to burn out fast!
How do leaders make their way to Medical Safety & Pharmacovigilance? The routes are diverse but one constant remains true: They are extremely committed to being an independent voice that amplifies their organization’s commitment to Patient Centricity.
Near the end of Jill Donahue’s family trip to Greece, an unlicensed tour guide, Charis, showed what communication mastery looks like.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.